Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Tilray Inc

Healthcare CA TLRY

9.83CAD
-0.14(1.40%)

Last update at 2026-03-10T20:00:00Z

Day Range

9.7410.17
LowHigh

52 Week Range

0.4821.57
LowHigh

Fundamentals

  • Previous Close 9.97
  • Market Cap1121.96M
  • Volume448084
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA23.17M
  • Revenue TTM837.32M
  • Revenue Per Share TTM8.27
  • Gross Profit TTM 234.67M
  • Diluted EPS TTM-32.1

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Type yearly yearly yearly yearly yearly
Date 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Income before tax -2302.37300M -249.02000M -1450.18100M -440.67400M -344.98600M
Minority interest -5.38200M -22.57700M -9.65600M -42.66900M 6.24M
Net income -2186.73800M -244.98100M -1443.00000M -434.13200M -336.01400M
Selling general administrative 166.40M 171.56M 230.94M 162.80M 111.58M
Selling and marketing expenses 93.09M 79.17M - 65.86M 44.12M
Gross profit 240.57M 223.35M 146.96M 116.82M 123.18M
Reconciled depreciation 133.49M 126.91M 130.15M 115.19M 67.83M
Ebit -2261.04200M -199.75600M - 153.29M -4.94700M
Ebitda -2127.55200M -72.84300M -1306.44500M 268.49M 30.27M
Depreciation and amortization 133.49M 126.91M - 115.19M 35.22M
Non operating income net other - - - - -
Operating income -2282.70500M -174.74500M -178.14700M 153.29M -4.94700M
Other operating expenses 3104.01M 963.69M - 856.92M 581.64M
Interest expense 41.33M 49.26M 13.59M 39.68M 30.90M
Tax provision -121.01700M -26.61600M -7.18100M -6.54200M -5.60200M
Interest income 11.38M 12.83M 33.02M 11.74M 26.05M
Net interest income -29.95200M -36.43300M -13.58700M -27.94400M -27.97700M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -121.01700M -26.61600M - -6.54200M -8.97200M
Total revenue 821.31M 788.94M 627.12M 628.37M 513.09M
Total operating expenses 2523.28M 398.10M 805.27M 345.37M 191.74M
Cost of revenue 580.74M 565.59M 480.16M 511.56M 389.90M
Total other income expense net -19.66800M -74.27500M -1258.44700M -593.96900M -340.03900M
Discontinued operations - - - - -
Net income from continuing ops -2181.35600M -222.40400M -1443.00000M -434.13200M -336.01400M
Net income applicable to common shares - - - -476.80100M -367.42100M
Preferred stock and other adjustments - - - - -
Breakdown 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Type yearly yearly yearly yearly yearly
Date 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Total assets 2074.33M 4221.66M 4307.26M 5449.69M 6025.36M
Intangible assets 21.42M 915.47M 973.78M 1277.88M 1605.92M
Earning assets - - - - -
Other current assets 34.09M 31.33M 37.72M 46.79M 48.92M
Total liab 584.75M 778.49M 977.32M 1008.33M 1560.05M
Total stockholder equity 1511.47M 3442.91M 3315.69M 4398.81M 4459.07M
Deferred long term liab - - - - -
Other current liab 16.09M 18.25M 18.04M 119.09M 293.93M
Common stock - 0.08M - 0.05M 0.05M
Capital stock 0.11M 0.08M 0.07M 0.05M 0.05M
Retained earnings -4847.22600M -2660.48800M -2415.50700M -962.85100M -486.05000M
Other liab - - - 196.83M 269.75M
Good will 752.35M 2008.88M 2008.84M 2641.30M 2832.79M
Other assets - - - 111.51M 8.29M
Cash 221.67M 228.34M 206.63M 415.91M 488.47M
Cash and equivalents - - - - -
Total current liabilities 280.30M 299.17M 432.98M 280.34M 401.24M
Current deferred revenue - 136.56M - - 155.11M
Net debt 35.20M 158.98M 373.14M 207.90M 450.19M
Short term debt - 38.96M - 92.65M 49.60M
Short long term debt 21.95M 33.87M 221.84M 85.95M 45.34M
Short long term debt total - 387.32M - 623.81M 938.66M
Other stockholder equity - 6146.81M - 5382.37M 4792.41M
Property plant equipment - - - 600.50M 668.97M
Total current assets 688.63M 677.71M 773.03M 803.50M 883.61M
Long term investments 10.13M 7.86M 12.37M 15.00M 25.79M
Net tangible assets - - - 479.62M 20.36M
Short term investments 34.70M 32.18M 241.90M - -
Net receivables 121.49M 101.69M 86.23M 95.28M 89.79M
Long term debt 234.92M 287.94M 357.93M 519.83M 306.26M
Inventory 270.88M 252.09M 200.55M 245.53M 256.43M
Accounts payable 107.35M 105.39M 70.82M 68.60M 57.71M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -43.49900M - -20.76400M 152.67M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 11.08M 5.39M 0.22M 111.51M 8.29M
Deferred long term asset charges - - - - -
Non current assets total 1385.70M 3543.95M 3534.23M 4646.19M 5141.75M
Capital lease obligations 71.87M 65.51M 10.36M 18.03M 58.21M
Long term debt total - - - - 870.59M
Breakdown 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Type yearly yearly yearly yearly yearly
Date 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Investments -46.71800M 128.35M -285.11100M -21.53300M 8.43M
Change to liabilities - - - -44.65200M 14.63M
Total cashflows from investing activities -46.71800M 128.35M - -21.53300M 46.10M
Net borrowings -26.13800M -83.80600M - -123.54600M 45.51M
Total cash from financing activities 133.51M -75.18700M 70.16M 128.20M 124.31M
Change to operating activities - - - 4.47M -6.77200M
Net income -2181.35600M -222.40400M -1443.00000M -434.13200M -336.01400M
Change in cash -6.67400M 21.71M -209.27700M -72.55700M 127.82M
Begin period cash flow 228.34M 206.63M 415.91M 488.47M 360.65M
End period cash flow 221.67M 228.34M 206.63M 415.91M 488.47M
Total cash from operating activities -94.59900M -30.90500M 7.91M -177.26200M -44.71700M
Issuance of capital stock 161.19M 8.62M 129.59M 262.51M 102.55M
Depreciation 133.49M 126.91M 130.15M 154.59M 67.83M
Other cashflows from investing activities 4.31M 209.72M - - 3.33M
Dividends paid - - - - -
Change to inventory -13.56100M -15.57800M -12.93400M -45.74900M -35.28600M
Change to account receivables -17.80100M -6.57500M 4.17M -5.84200M -23.51200M
Sale purchase of stock 0.00000M 0.00000M -1.18900M - 220.20M
Other cashflows from financing activities -1.54400M -2.90000M - -1.36100M 87.38M
Change to netincome - - - 236.72M 325.73M
Capital expenditures 32.92M 29.25M 20.80M 34.06M 38.87M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -62.56400M -8.87200M 14.40M -91.77100M -50.93500M
Stock based compensation 24.29M 31.77M 39.59M 35.99M 17.35M
Other non cash items 2112.56M 80.56M 258.59M 185.59M 281.92M
Free cash flow -127.51600M -60.15400M -12.89400M -211.32600M -83.59100M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TLRY
Tilray Inc		 -0.14 1.40% 9.83 - 1000.00 1.34 0.56 1.09 -2.299
BHC
Bausch Health Companies Inc		 0.08 1.10% 7.33 5.94 1.34 0.29 18.74 2.18 6.64
CURA
Curaleaf Holdings Inc.		 0.02 0.65% 3.08 - 138.89 1.90 2.05 1.88 11.75
CRON
Cronos Group Inc		 0.01 0.29% 3.44 23.40 32.26 10.16 0.92 1.27 -1.9458
WEED
Canopy Growth Corp		 -0.02 1.37% 1.44 - 20.49 2.32 0.83 2.04 -1.5049

Reports Covered

Stock Research & News

View All

Profile

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Cruisies, Atwater Brewery, Hiball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company, SweetWater Brewing Company, Terrapin Beer Co., Happy Flower, Fizzy Jane's, Herb & Bloom, 420 Fizz, and Fresh Hemp Foods brands. The company sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Tilray Inc

265 Talbot Street West, Leamington, ON, Canada, N8H 5L4

Key Executives

Name Title Year Born
Mr. Irwin David Simon Pres, CEO & Chairman 1958
Mr. Carl A. Merton CA, CBV, CPA CFO & Principal Accounting Officer 1970
Mr. Mitchell S. Gendel Global Gen. Counsel & Corp. Sec. 1966
Mr. James R. Meiers Sr. VP of U.S. Operations 1958
Ms. Denise Menikheim Faltischek Chief Strategy Officer & Head of International 1973
Mr. Lloyd Brathwaite Chief Information Officer NA
Mr. Roger Savell Chief Admin. Officer NA
Mr. John B. Sadler VP of Investor Relations NA
Ms. Dara S. Redler Interim Chief Legal Officer & Corp. Sec. NA
Mr. Bernard Yeung Sr. VP of Sales & Marketing NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.